Harvard Bioscience (NASDAQ:HBIO) Closing price on Thursday: $5.75
The firm posted its fourth-quarter revenue at $28.2 million, compared to one estimate of $29.2 million. Also, the company reported fourth-quarter adjusted earnings from continuing operations for its core Life Science Research Tools unit at 10 cents. Shares closed down 0.69 percent on the day at $5.75, and have been traded in a 52-week range of $3.45 to $5.86.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more